Tuesday, October 19, 2021

Avivagen Inc. (VIVXF)(VIV:CA)
6.3 Tonne Order Received

Avivagen Inc is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal’s own health defenses. Its product range includes OxC-beta, Vivamune health chews, Oximunol chewable tablets, and Carotenoid Oxidation products.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Order. Avivagen signed a significant new purchase agreement to supply its largest customer in Asia with a 6.3 tonne order of OxC-beta Livestock. The shipment represents a 43% increase in size over the customer’s previous order and continues a trend of increased reorder size among this and other OxC-beta customers worldwide.


UNAHCO.  Although the Company did not release the name of the customer, we believe it is UNAHCO, out of the Philippines. Since its initial November 2016 order of 150 kilograms of OxC-beta, the growth in UNAHCO’s orders is stunning. Just starting in November 2019, orders grew from 2.1 tonnes, to 3.0 tonnes in April 2020, to 4.0 tonnes in October 2020, to 4.4 tonnes in April 2021, to the 6.3 tonne …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.